Learn how CALM uses continuous vectors to bypass the token bottleneck and cut AI compute by up to 40%. Continuous ...

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Good morning, and welcome to the Regal Rexnord Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event ...

We consider estimation of Bayesian network structures given a finite number of examples when both discrete and continuous random variables are present in a Bayesian network. It is not hard to estimate ...

The global Clean Power VFD Market is anticipated to grow from estimated USD 1.16 billion in 2025 to USD 1.52 billion by 2030, ...

Monolithic Power Systems has delivered exceptional, organic revenue growth and profitability, driven by proprietary power-management IP, customer integration, and an efficient fabless model. MPWR ...

Q3 2025 Earnings Call Transcript October 23, 2025 Pool Corporation beats earnings expectations. Reported EPS is $3.39, expectations were $3.38. Operator: Good day, and welcome to the POOLCORP Third ...

Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsSteve AlexanderDaniel Rivera - President, CEO ...

A mission to search for the origin-of-life on Titan, Saturn's largest moon, will be aided by University of Otago – Ōtākou ...

Abstract: Computing stabilizing and optimal control actions for legged locomotion in real time is difficult due to the nonlinear, hybrid, and high dimensional nature of these robots. The hybrid nature ...

Objectives To alleviate the shortage of qualified physicians in rural areas, since 2010, the Chinese government has launched a National Compulsory Service Programme (NCSP) to enrol medical students ...

Objectives To determine what drives participation in clinical trials with decentralised elements and to estimate trial participation probabilities for trials with different degrees of decentralisation ...

Background: This study investigates the relationship between the systemic immune-inflammation index (SII) and all-cause mortality (ACM) risk in individuals with stages IIIB–IV epidermal growth factor ...